Clinical Trials Financial Disclosures by Investigator
| Reviewed By | Internal Auditor Owner |
| URL: | https://www.nmu.edu/policies?processtype=parent&action=SearchPolicies&phase=phase2&elementid=658&subaction=Policy |
| Regulation Reference Cite | 21 C.F.R. § 54 |
| Level | Requirement |
| Oversight Unit | GRADUATE STUDIES & RESEARCH, COLLEGE OF |
| Person Responsible | TBD |
| Secondary Person Responsible | TBD |
| President / VP Level | Provost |
| Description |
Clinical investigators are required to disclose financial arrangements with sponsor(s) of the studies (such as payment and royalties) and interests in the product under study or sponsor entity (i.e. proprietary interest such as a patent or other equity interest and conflict of interest). |
| Contacts and Data Sources |
| Dr. Susy Ziegler |
| Internal Notes |
| This compliance item has notes that are available internally to the oversight unit. Please contact the Risk Management Department for more information |